Hepatitis Newswire (Page 8)

Hepatitis Newswire (Page 8)

Comprehensive Real-Time News Feed for Hepatitis. (Page 8)

Results 141 - 160 of 27,238 in Hepatitis

  1. Andreas Halvorsen Gains - Stakes for Backing Hot Biotech RoivantRead the original story w/Photo

    Thursday Jul 14 | GuruFocus.com

    ... Roivant owns 16,013,540 shares, or 29.3%, of Arbutus Biopharma Corp. ( NASDAQ:ABUS ), which is pursuing a cure for hepatitis B. Roivant acquired most of the shares on March 25, 2015. Arbutus formed when Tekmira Pharmaceuticals merged with OnCore ...

    Comment?

  2. Halvorsen Funds Company Buying Neglected Drugs, Gets Stakes in - BiotechsRead the original story w/Photo

    Thursday Jul 14 | GuruFocus.com

    ... Roivant owns 16,013,540 shares, or 29.3%, of Arbutus Biopharma Corp. ( NASDAQ:ABUS ), which is pursuing a cure for hepatitis B. Roivant acquired most of the shares on March 25, 2015. Arbutus formed when Tekmira Pharmaceuticals merged with OnCore ...

    Comment?

  3. Barry Haarde Cycles Across the USA for 'Wheels for the World:...Read the original story w/Photo

    Friday Jul 15 | PRWeb

    ... a contaminated blood product for his hemophilia. After surviving a grueling multi-year treatment to cure his hepatitis in his early forties, Barry decided to make his condition public. Since then Barry has been symbol of courage, determination and ...

    Comment?

  4. Barriers to sexual health care: a survey of Iranian-American physicians in California, USARead the original story w/Photo

    Thursday Jul 14 | BioMed Central

    ... 110 million. Among those 15 years and older, these estimates included eight common STIs: chlamydia, gonorrhoea, hepatitis B virus (HBV), herpes simplex virus type 2 (HSV-2), human immunodeficiency virus (HIV), human papillomavirus (HPV), syphilis, ...

    Comment?

  5. 2 attorneys withdraw from hepatitis C lawsuitRead the original story

    Thursday Jul 14 | KFYR-TV Bismarck

    There's been a slight shuffling of lawyers in the federal lawsuit surrounding one of the largest Hepatitis C outbreaks in U.S. history. Federal court records indicate that two of the attorneys representing the assisted living center ManorCare have withdrawn themselves from the case.

    Comment?

  6. Mobile clinic offers immunizations todayRead the original story w/Photo

    Thursday Jul 14 | Amarillo.com

    A mobile adult immunization clinic conducted by the City of Amarillo's Public Health Department will be in operation from noon to 5 p.m. today at the former Toot'n Totum location at 1306 E. Amarillo Blvd. The immunizations that will be available, while supplies last, include Pneumococcal, MMR, TDAP, Varicella, Flu, TD, HPV, Meningitis, Hepatitis A and B and Twinrix . Please Note: You may have disabled JavaScript and/or CSS.

    Comment?

  7. Andreas Halvorsen's Viking Global Gets Control of Stakes in - Companies for Backing Hot BiotechRead the original story

    Thursday Jul 14 | GuruFocus.com

    ... Roivant owns 16,013,540 shares, or 29.3%, of Arbutus Biopharma Corp. ( NASDAQ:ABUS ), which is pursuing a cure for hepatitis B. Roivant acquired most of the shares on March 25, 2015. Arbutus formed when Tekmira Pharmaceuticals merged with OnCore ...

    Comment?

  8. Afraid of 'dying on the streets': homeless man turned away from hospitalRead the original story w/Photo

    Thursday Jul 14 | Illawarra Mercury

    Suffering end stage liver disease due to alcohol abuse and hepatitis C, he has limited mobility, requires weekly fluid draining from his abdomen and such low blood pressure that a doctor advised in a letter that he was "likely to faint or pass out on minimal exertion''. The letter - dated June 10, 2016 - stated the 44-year-old's life expectancy was "measured in weeks, perhaps two to three months at most''.

    Comment?

  9. Gilead Sciences: A Move On Earnings And A Low P/E?Read the original story w/Photo

    Thursday Jul 14 | Seeking Alpha

    The company has some strong possibilities in the pipeline, as well as a growing HIV business, but competition from Merck in the Hepatitis C segment is a broadening threat. As a whole, a missed Q1 has thrown off their 2016 and their lack of a big catalyst for growth thus far points for a boring year.

    Comment?

  10. Abort, Retry, Fail - Billionaire Bill Gates Opines, Sans Evidence, on ...Read the original story w/Photo

    Thursday Jul 14 | Health Care Renewal

    ... the efficacy of pharmaceuticals? Software Mogul Bill Gates on the Pricing and Efficacy of Antiviral Drugs for Hepatitis C Nonetheless, per Bloomberg , last week Bill Gates pontificated about drugs for the treatment of hepatitis C. When apparently ...

    Comment?

  11. Notifiable Diseases and Mortality TablesRead the original story

    Thursday Jul 14 | Centers for Disease Control and Prevention

    ... (NCIRD). **** Updated weekly from reports to the Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Prior to 2015, CDC's National Notifiable Diseases Surveillance System (NNDSS) did not receive ...

    Comment?

  12. Report as OffensiveRead the original story w/Photo

    Thursday Jul 14 | The Walkerton Herald Times

    An Epclusa bottle and pill are shown in this undated handout photo. Health Canada has approved a drug being touted as a cure for hepatitis C, a disease believed to have infected hundreds of thousands of Canadians, many of whom are unaware they harbour the virus.

    Comment?

  13. Health Canada approves drug doctors call cure for hepatitis CRead the original story

    Thursday Jul 14 | MacLeans

    ... for a 12-week course. Or more than $700 per pill. Health Canada has approved a drug being touted as a cure for hepatitis C, a disease believed to have infected hundreds of thousands of Canadians, many of whom are unaware they harbour the virus. The ...

    Comment?

  14. Yisheng Biopharma And The United States Army Medical Research...Read the original story

    Wednesday Jul 13 | BioSpace

    ... rabies vaccine. PIKA adjuvant has also exhibited great potential in preclinical studies in vaccines against HIV, Hepatitis-B, influenza, tuberculosis, and other viruses, and the company's phase 2 PIKA rabies vaccine trial is expected to be completed ...

    Comment?

  15. Scientists explore ways to make fat cells function better during obesityRead the original story w/Photo

    Thursday Jul 14 | Medical News

    ... beige fat. It also reduces fatty deposits on the liver, another sign of fat-cell dysfunction that can cause hepatitis. In fact, they've shown that mice missing HDAC9 express more beige-fat producing genes than even typically lean, normal mice. "The ...

    Comment?

  16. Health Canada approves drug doctors call cure for hepatitis C infectionRead the original story w/Photo

    Thursday Jul 14 | The Globe and Mail

    Health Canada has approved a drug being touted as a cure for hepatitis C, a disease believed to have infected hundreds of thousands of Canadians, many of whom are unaware they harbour the virus. The drug, sold under the brand name Epclusa, is a once-daily pill taken for 12 weeks that can rid the body of all six strains of hepatitis C, a blood-borne virus that can lead to severe liver damage and liver cancer if left untreated.

    Comment?

  17. Another reason to get a vaccinationRead the original story

    Thursday Jul 14 | The Honolulu Advertiser

    The state seems to be dealing with one community health scare after another - dengue fever, Zika virus and now hepatitis A. Read More

    Comment?

  18. Dire need for men's refugeRead the original story w/Photo

    Thursday Jul 14 | Illawarra Mercury

    ... to palliative care is an appropriate option.'' Suffering end stage liver disease due to alcohol abuse and hepatitis C, he has limited mobility, requires weekly fluid draining from his abdomen and such low blood pressure that a doctor advised in a ...

    Comment?

  19. Gilead Receives Approval In Canada For EPCLUSA...Read the original story

    Wednesday Jul 13 | BioSpace

    ... the first once-daily, pan-genotypic single tablet regimen for the treatment of adults with genotype 1-6 chronic hepatitis C virus (HCV) infection. EPCLUSA - for 12 weeks - is for use in patients without cirrhosis or with compensated cirrhosis, and ...

    Comment?

  20. Viral Hepatitis Is Now A Major Global Cause of Death, Exceeding HIV and TuberculosisRead the original story w/Photo

    Wednesday Jul 13 | HIV and Hepatitis

    Chronic hepatitis B and C have become leading causes of death and disability worldwide, as other major communicable diseases such as HIV/AIDS, malaria, and tuberculosis have come under better control, according to an analysis published in the July 8 online edition of The Lancet . JD Stanaway, AD Flaxman, M Naghavi, GS Cooke, et al. GS Cooke, The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013.

    Comment?